Clinical Trial Update: Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating acalabrutinib in combination with RICE for relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)

Snippet

Sponsor: Swedish Medical Center | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN